Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
NK cell therapy SNK01 cleared for moderate Alzheimer’s Phase 2 trial
https://alzheimersnewstoday.com/news/nk-cell-therapy-snk01-cleared-moderate-alzheimers-phase-2-trial/
links
backlinks
Tagged with:
moderate alzheimer
The Phase 2 study will further assess SNK01's safety and its efficacy in about 30 patients who'll receive it every three weeks up to a year.
Roast topics
Find topics
Find it!
